Kintara Therapeutics News

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 14 16:00

S-4: Registration of securities issued in business combination transactions

May 13 15:13

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 25 08:09

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 3 06:17

Kintara Therapeutics | 424B5: Prospectus

Dec 18, 2023 15:05

Kintara Therapeutics | 424B5: Prospectus

Sep 19, 2023 15:16

Kintara Therapeutics | 424B5: Prospectus

Aug 3, 2022 08:07

Kintara Therapeutics | 424B5: Prospectus

Apr 13, 2022 15:16

Kintara Therapeutics | 424B5: Prospectus

Sep 27, 2021 16:28

Kintara Therapeutics | EFFECT: Others

Apr 1, 2021 23:15

Kintara Therapeutics | EFFECT: Others

Nov 4, 2020 23:15

Kintara Therapeutics | 424B4: Prospectus

Nov 4, 2020 15:44

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 18, 2020 07:41

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 17, 2020 08:02

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 28, 2020 15:57

Kintara Therapeutics | EFFECT: Others

Jul 5, 2020 23:15

Kintara Therapeutics | 424B3: Prospectus

Jul 2, 2020 15:45

Kintara Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jul 1, 2020 18:59

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 24, 2020 16:11

Kintara Therapeutics | S-4: Registration of securities issued in business combination transactions

Jun 16, 2020 16:11